Significant attention has been directed towards the Wnt/CTNNB1 and TP53 signaling pathways, which are frequently mutated in ACC, particularly with respect to CTNNB1 (beta-catenin) and P53 staining [11,12,13]. This evidence concerns the gene TP53 and adrenal cortex carcinoma.